Morphological characteristics of human extrahepatic bile duct carcinoma

Biomedical Research

Volumn 24, Issue 5, 2003, Pages 261-267

  Sakuma, Toshiyuki ^a   Kijima, Hiroshi ^a   Kashiwagi, Hiroyuki ^a   Dowaki, Shoichi ^a   Ohtani, Yasuo ^a   Imaizumi, Toshihide ^a   Makuuchi, Hiroyasu ^a   Watanabe, Hidenobu ^b   Yamazaki, Hitoshi ^a   Nakamura, Masato ^a   Ueyama, Yoshito ^a   Mine, Tetsuya ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC TEST; EARLY CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; MUCOSA; MUSCLE CANCER; NERVE TUMOR; PATHOLOGY; SMOOTH MUSCLE FIBER; VASCULAR TUMOR;

EID: 27244433738     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.24.261     Document Type: Article

References (34)

1. Albores-Saavedra J., Henson D. E. and Klimstra D. S. (1998) Tumors of the gallbladder, extrahepatic bile ducts and ampulla of Vater. In: Atlas of Tumor Pathology. Third Series Fascicle 27, pp171-210, Armed Forces Institute of Pathology, Washington, D. C.
2. Albores-Saavedra J., Menck H. R., Scoazec J. C., Soehendra N., Wittekind C., Sriram P. V. J. and Sripa B. (2000) Carcinoma of the gallbladder and extrahepatic bile ducts. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of the Digestive System. (Hamilton S. R. and Aaltonen L. A., eds.), pp206-214, IARC Press, Lyon.
3. Altmannsberger M., Weber K., Droste R and Osborn M. (1985) Desmin is a specific marker for rhabdomyosarcomas of human and rat origin. Am. J. Pathol. 118, 85-95.
4. Avrameas S. and Ternynck T. (1971) Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration. Immunochemistry 8, 1175-1179.
5. Beazley R. M., Hadjis N., Benjamin I. S. and Blumgart L. H. (1984) Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments. Ann. Surg. 199, 623-636.
6. Cui X., Hui A. M., Li X., Shi Y. Z., Takayama T., Hatakeyama K. and Makauchi M. (2000) Alterations of retinoblastoma protein and p16INK4 protein expression in extrahepatic bile duct carcinomas. Hepatogastroenterology 47, 1216-1220.
7. Day D. W., Jass J. R., Price A. B., Shepherd N. A., Sloan J. M., Talbot I. C., Warren B. F. and Williams G. T. (2003) Morson and Dawson's Gastrointestinal Pathology, 4th ed., pp. 174-177, Blackwell Publishing, Massachusetts.
8. Dowaki S., Kijima H., Kashiwagi H., Ohtani Y., Tobita K., Tsukui M., Tanaka Y., Tazawa K., Matsubayashi H., Tsuchida T., Nakamura M., Ueyama Y., Tanaka M., Tajima T. and Makuuchi H. (2000) CEA immunohistochemical localization is correlated with growth and metastasis of human gallbladder carcinoma. Int. J. Oncol. 16, 49-53.
9. Dunbar L. L., Adkins R. B., Farringer J., Waterhouse G. and O'Leary J. P. (1983) Carcinoma of the gallbladder and bile ducts: A retrospective review. Am. Surg. 49, 94-104.
10. Evander A., Fredlund P., Hoevels J., Ihse I. and Bengmark S. (1980) Evaluation of aggressive surgery for carcinoma of the extrahepatic bile ducts. Ann. Surg. 191, 23-29.
11. Frierson H. F. Jr. (1997) Gallbladder and extrahepatic biliary system. In: Histology for Pathologists, 2nd ed. (Sternberg S.S., ed.), pp 600-603, Lippincott-Raven, Philadelphia.
12. Hida Y., Morita T., Fujita M., Miyasaka Y., Horita S., Fujioka Y., Nagashima K. and Katoh H. (1999) Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas. Anticancer Res. 19, 2257-2260.
13. Ichikawa K., Imura J., Kawamata H., Takeda J. and Fujimori T. (2002) Down-regulated p16 expression predicts poor prognosis in patients with extrahepatic biliary tract carcinomas. Int. J. Oncol. 20, 453-461.
14. Ito Y., Takeda T., Sakon M., Monden M., Tsujimoto M. and Matsuura N. (2000) Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct. Anticancer Res. 20, 337-344.
15. Japanese Society of Biliary Surgery. (2001) Classification of Biliary Tract Carcinoma, 1st ed., p25, Kanehara Co., Ltd., Tokyo.
16. Kashiwagi H., Kijima H., Dowaki S., Ohtani Y., Tobita K., Tsukui M., Tanaka Y., Matsubayashi H., Tsuchida T., Yamazaki H., Nakamura M., Ueyama Y., Tanaka M., Tajima T. and Makuuchi H. (2000) DF3 expression in human gallbladder carcinoma: Its significance for lymphatic invasion. Int. J. Oncol. 16, 455-459.
17. Kashiwagi H., Kijima H., Dowaki S., Ohtani Y., Tobita K., Yamazaki H., Nakamura M., Ueyama Y., Tanaka M., Inokuchi S. and Makuuchi H. (2001) MUC1 and MUC2 expression in human gallbladder carcinoma: A clinicopathological study and relationship with prognosis. Oncology Reports 8, 485-489.
18. Kenjo A., Abe T., Saito T., Tsuchiya T., Yamada F., Kanzaki N. and Gotoh M. (2000) Mucin ball-producing extrahepatic bile duct carcinoma. Scand. J. Gastroenterol. 35, 1330-1334.
19. a expression is correlated with vascular invasion of human gallbladder adenocarcinoma. Int. J. Oncol. 17, 55-60.
20. Kijima H., Watanabe H., Iwafuchi M. and Ishihara N. (1989) Histogenesis of gallbladder carcinoma from investigation of early carcinoma and microcarcinoma. Acta Pathol. Jpn. 39, 235-244.
21. Lack E. E., Khettry U. and Legg M. A. (1990) The pancreas and extrahepatic billiary system: extrahepatic bile ducts. In: Principles and Practice of Surgical Pathology, 2nd ed. (Silverberg S. G., ed.), pp1378-1381, Churchill Livingstone, New York.
22. Lazard D., Sastre X., Frid M. G., Glukhova M. A., Thiery J. P. and Koteliansky V. E. (1993) Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc. Natl. Acad. Sci. USA 90, 999-1003.
23. Miettinen M., Lehto V. P., Ekblom P., Tasanen A. and Virtanen I. (1984) Leiomyosarcoma of the mandible: diagnosis as aided by immunohistochemical demonstration of desmin and laminin. J. Oral Pathol. 13, 373-381.
24. Mills S. E., Bova G. S., Wick M. R. and Young R. H. (1989) Leiomyosarcoma of the urinary bladder. A clinicopathologic and immunohistochemical study of 15 cases. Am. J. Surg. Pathol. 13, 480-489.
25. Ogura Y., Takahashi K., Tabata M. and Mizumoto R. (1994) Clinicopathological study on carcinoma of the extrahepatic bile duct with special focus on cancer invasion on the surgical margins. World J. Surg. 18, 778-784.
26. Ohtani Y., Kijima H., Dowaki S., Kashiwagi H., Tobita K., Tsukui M., Tanaka Y., Tsuchida T., Tokunaga T., Yamazaki H., Nakamura M., Ueyama Y., Tanaka M., Tajima T. and Makuuchi H. (1999) Stromal expression of thrombospondin-1 (TSP1) is correlated with growth and metastasis of human gallbladder carcinoma. Int. J. Oncol. 15, 453-457.
27. Rønnov-Jessen L. and Petersen O. W. (1996) A function for filamentous α-smooth muscle actin: retardation of motility in fibroblasts. J. Cell Biol. 134, 67-80.
28. Saul S. H. (1994) Gallbladder and extrahepatic biliary tree. In: Diagnostic Surgical Pathology. (Sternberg S. S., ed.), pp1604-1607, Raven Press, New York.
29. Sobin L. H. and Wittekind C. (eds.) (1997) Extrahepatic bile duct. In: TNM Classification of Malignant Tumours, 4th ed., pp 81-83, Wiley-Liss, New York.
30. Sons H. U. and Borchard F. (1987) Carcinoma of the extrahepatic bile duct: a postmortem study of 65 cases and review of the literature. J. Surg. Oncol. 34, 6-12.
31. Sugiyama M., Atomi Y., Kuroda A. and Muto T. (1997) Bile duct carcinoma without jaundice: clues to early diagnosis. Hepatogastroenterology 44, 1477-1483.
32. Tamada S., Goto M., Nomoto M., Nagata K., Shimizu T., Tanaka S., Sakoda K., Imai K. and Yonezawa S. (2002) Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Pathol. Int. 52, 713-723.
33. Tanaka H., Kijima H., Tokunaga T., Tajima T., Himeno S., Kenmochi T., Oshiba G., Kise Y., Nishi T., Chino O., Shimada H., Machimura T., Tanaka M. and Makuuchi H. (1999) Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas. Int. J. Oncol. 14, 1069-1073.
34. Van Muijen G. N. P., Ruiter D. J. and Warnaar S. O. (1987) Coexpression of intermediate filament polypeptides in human fetal and adult tissues. Lab. Invest. 57, 359-369.